We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
-19.83%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$2.79B
AUM Growth
-$1.14B
Cap. Flow
-$180M
Cap. Flow %
-6.46%
Top 10 Hldgs %
13.46%
Holding
340
New
37
Increased
107
Reduced
122
Closed
41

Top Sells

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$34.9M
2
TDOC icon
Teladoc Health
TDOC
+$33.4M
3
IT icon
Gartner
IT
+$20.8M
4
AGCO icon
AGCO
AGCO
+$20.4M
5
GIII icon
G-III Apparel Group
GIII
+$20.3M

Sector Composition

Rank Sector Weight
1 Healthcare 24.01%
2 Technology 23.97%
3 Financials 15.39%
4 Industrials 10.74%
5 Consumer Discretionary 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFIN icon
101
Triumph Financial Inc
TFIN
$1.82B
$11.5M 0.41%
442,262
+1,611
+0.4% +$55.8K
ARGO
102
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$11.5M 0.41%
309,868
+1,041
+0.3% +$59.1K
GKOS icon
103
Glaukos
GKOS
$10.7B
$11.5M 0.41%
371,902
-44,514
-11% -$2.28M
ZUO
104
DELISTED
Zuora, Inc.
ZUO
$11.4M 0.41%
1,416,101
+222,879
+19% +$2.93M
IOVA icon
105
Iovance Biotherapeutics
IOVA
$2.94B
$11.4M 0.41%
379,418
-162,558
-30% -$4.31M
WNC icon
106
Wabash National
WNC
$505M
$11.3M 0.4%
1,558,520
+569,007
+58% +$6.38M
PCRX icon
107
Pacira BioSciences
PCRX
$972M
$11.3M 0.4%
335,519
+457
+0.1% +$19K
HQY icon
108
HealthEquity
HQY
$8.83B
$11M 0.39%
217,762
-27,066
-11% -$1.8M
ADPT icon
109
Adaptive Biotechnologies
ADPT
$4.04B
$10.7M 0.38%
385,590
+90,041
+30% +$2.51M
IONS icon
110
Ionis Pharmaceuticals
IONS
$9.21B
$10.5M 0.38%
222,342
+11,499
+5% +$641K
VRTS icon
111
Virtus Investment Partners
VRTS
$1.11B
$10.3M 0.37%
135,373
+429
+0.3% +$48.4K
GBT
112
DELISTED
Global Blood Therapeutics, Inc.
GBT
$10.3M 0.37%
+201,098
New +$13.5M
WWD icon
113
Woodward
WWD
$21.1B
$10.2M 0.37%
172,016
-25,549
-13% -$2.65M
IMMU
114
DELISTED
Immunomedics Inc
IMMU
$10.2M 0.37%
757,275
+70,402
+10% +$1.18M
PHR icon
115
Phreesia
PHR
$758M
$10.2M 0.36%
483,431
+37,444
+8% +$1.03M
NVCR icon
116
NovoCure
NVCR
$2.06B
$10.1M 0.36%
150,689
+554
+0.4% +$43.8K
TCMD icon
117
Tactile Systems Technology
TCMD
$547M
$9.91M 0.36%
246,756
-169,434
-41% -$9.08M
EEFT icon
118
Euronet Worldwide
EEFT
$2.64B
$9.71M 0.35%
113,249
-63,070
-36% -$8.36M
MDRX
119
DELISTED
Veradigm Inc. Common Stock
MDRX
$9.67M 0.35%
1,373,187
+2,587
+0.2% +$21K
STAY
120
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$9.59M 0.34%
1,312,276
-3,744
-0.3% -$43K
FORM icon
121
FormFactor
FORM
$9.46B
$9.21M 0.33%
458,397
-302,942
-40% -$7.23M
PINC
122
DELISTED
Premier
PINC
$9.12M 0.33%
278,583
+278,333
+111,333% +$9.08M
VRRM icon
123
Verra Mobility
VRRM
$726M
$8.77M 0.31%
1,227,830
-55,129
-4% -$734K
OPLN
124
Openlane
OPLN
$4.48B
$8.41M 0.3%
700,821
+282,891
+68% +$5.53M
CERS icon
125
Cerus
CERS
$517M
$8.09M 0.29%
1,739,837
-642,829
-27% -$2.91M

Similar funds

Peregrine Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Peregrine Capital Management held 340 positions worth $2.79B, down 29% from $3.93B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Peregrine Capital Management withdrew a net $180M in Q1 2020, closing 41 positions and reducing 122 holdings. Its most notable exit was Caesars Entertainment, an estimated $34.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

Against the trend, Peregrine Capital Management opened a new position in Uber worth $25.9M.

  • Peregrine Capital Management's largest Q1 2020 buy was Uber: 926,512 shares worth $25.9M.
  • Peregrine Capital Management added most to KBR in Q1 2020, an estimated $11M increase.
  • Peregrine Capital Management's biggest Q1 2020 reduction was Teladoc Health, cutting an estimated $33.4M.
  • Peregrine Capital Management fully exited Caesars Entertainment in Q1 2020, selling an estimated $34.9M.
  • Peregrine Capital Management's ten largest holdings make up 13% of its $2.79B portfolio in Q1 2020.
  • Peregrine Capital Management opened 37 new positions and closed 41 in Q1 2020.
  • Peregrine Capital Management's portfolio value fell 29% quarter-over-quarter to $2.79B.

Based on Peregrine Capital Management's 13F filing for Q1 2020, filed 17 Apr 2020.